Company News

This press release is posted as a service by Angioplasty.Org


Medtronic plc
Company Press Releases

Oct 12, 2023 Medtronic Receives CE Mark for Evolut™ FX TAVI System for Treatment of Severe Aortic Stenosis
May 1, 2023 Medtronic Receives FDA Approval For Its Next Generation Micra Leadless Pacing Systems
Mar 5, 2023 Three-Year Results of Medtronic's Evolut TAVR Compared to Surgery in Low Risk Patients
Presented at ACC
Feb 27, 2023 Medtronic CoreValve/Evolut™ Demonstrates Best Durability
Feb 1, 2023 Medtronic Continues to Make Significant Advances as an Inclusion, Diversity & Equity Leader
Jan 11, 2023 Medtronic Announces First Enrollment in Head-to-Head Global Randomized Trial Evaluating Durability of Endovascular Aneurysm Repair
Dec 5, 2022 Medtronic Completes Enrollment in Pivotal Trial Evaluating First-Of-Its-Kind Pulsed Field Ablation Catheter for Patients with Atrial Fibrillation
Nov 29, 2022 Medtronic’s Next-Gen Evolut™ FX TAVR System Shows Significant Improvement in Commissure Alignment in Real World Setting
Nov 7, 2022 SPYRAL HTN-ON MED Study Demonstrates Meaningful Clinical Benefits Consistent with Other SPYRAL HTN Renal Denervation Trials
Nov 2, 2022 Clinical Studies Show Medtronic Drug Coated Balloon Outperforms Bare Metal Stents; Maintains Performance in Real World
Sep 21, 2022 Medtronic is the First and Only Company to Receive FDA Indication for Bifurcation Percutaneous Coronary Intervention with a Drug-Eluting Stent
Sep 20, 2022 Medtronic Receives FDA Clearance for Expanded Indication of LINQ II™ Insertable Cardiac Monitor for Use in Pediatric Patients Ages 2 and Older
Sep 18, 2022 TCT 2022: SYMPLICITY HTN-3 Trial Data Show Sustained Long-Term Blood Pressure Reductions With Medtronic Renal Denervation Procedure
Sep 16, 2022 Medtronic Announces Full Market Launch in U.S. of Evolut™ Fx Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
Jul 12, 2022 Medtronic Announces Co-promotion Agreement with CathWorks, with Path Toward Acquisition
May 27, 2022 Medtronic Low-Profile Drug-Coated Balloon Platform Receives U.S. FDA Approval to Treat Peripheral Arterial Disease
May 17, 2022 Optimized Procedure and Care Pathway with Medtronic Evolut™ TAVR System Demonstrates Excellent Valve Performance and Procedural Outcomes
May 17, 2022 EuroPCR: Medtronic Renal Denervation System Shows Better Blood Pressure Control with Significantly More Time in Target Range
May 13, 2022 Medtronic Receives FDA Approval for Latest Generation Drug-Eluting Coronary Stent System
May 2, 2022 Medtronic Announces First Enrollment in Pivotal Trial of Patients with Moderate, Symptomatic Aortic Stenosis
Apr 27, 2022 IN.PACT™ AV Drug-Coated Balloon First and Only to Show Sustained and Superior Performance Compared to PTA Through 36 Months
Apr 25, 2022 Medtronic Names New Chief Scientific, Medical, and Regulatory Officer
Apr 4, 2022 Medtronic TAVR Platform First and Only To Demonstrate Durability Benefit Over SAVR At 5 Years
Sep 28, 2021 Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio
Jul 26, 2021 Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
May 18, 2021 Medtronic Evolut™ TAVR System Shows Strong Performance at Two Years in Low Risk Trial
May 3, 2021 Medtronic Announces CE Mark of Evolut™ PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe
Mar 26, 2021 Medtronic Receives FDA Approval for "Breakthrough" Transcatheter Pulmonary Valve Replacement for Patients with Congenital Heart Disease
Oct 1, 2020 Medtronic Resolute Onyx™ Drug Eluting Stent (DES) First to Receive One-Month DAPT Labeling in the U.S. with Expanded Indication for High Bleeding Risk Patients
Jun 16, 2020 ABRE Study Meets Primary Safety and Effectiveness Endpoints
Jun 5, 2020 Medtronic Resolute Onyx™ DES Receives First and Only One-Month DAPT Indication for High Bleeding Risk Patients in Europe
May 18, 2020 Jeffrey J. Popma, M.D. to Join Medtronic as Vice President and Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart Businesses
Mar 18, 2020 Medtronic Continuing to Increase Ventilator Production to Address COVID-19 Pandemic
Feb 4, 2020 Medtronic Begins New Pilot Study as Part of SPYRAL HTN Clinical Program for Renal Denervation in Hypertension Patients
Sep 23, 2019 Medtronic Announces FDA Approval and U.S. Launch of Next-Generation Evolut™ PRO+ TAVR System for Treatment of Symptomatic Severe Aortic Stenosis Patients
Sep 7, 2019 IN.PACT AV Access Trial Meets Primary Safety and Effectiveness Endpoints
Aug 16, 2019 Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality
Mar 16, 2019 Medtronic Evolut Low Risk Trial Meets Primary Endpoint
Jan 30, 2019 Medtronic Valiant™ Captivia™ Demonstrates Durability, Safety, and Efficacy at Five Years in Transection Patients
Jan 15, 2019 Medtronic Launches Mobile App That Communicates Directly with World's First Smartphone-Connected Pacemakers
Nov 13, 2018 Medtronic Receives CE Mark Approval for the Valiant Navion™ Thoracic Stent Graft System
Nov 6, 2018 Medtronic Presents IN.PACT SFA Trial Five-Year Data and Total IN.PACT All-Subjects Analysis in VIVA Late Breaking Clinical Trials
Oct 23, 2018 Medtronic Receives FDA Approval for Valiant Navion™ Thoracic Stent Graft System
Sep 24, 2018 Medtronic Builds on TAVR Clinical Evidence Portfolio with Five-Year CoreValve Durability Data and Complete Two-Year Outcomes in Intermediate Risk Aortic Stenosis Patients
Sep 22, 2018 Medtronic Presents IN.PACT Global Study Three-Year Data and Total IN.PACT™ Imaging and Propensity Analyses
Aug 15, 2018 Medtronic Announces Commercial Launch of the IN.PACT™ Admiral™ Drug-Coated Balloon in Japan
Jun 15, 2018 Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT™ Admiral™ Drug Coated Balloons
Apr 23, 2018 Medtronic IN.PACT™ Admiral™ Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions
Apr 5, 2018 Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
Feb 26, 2018 Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels
Jan 30, 2018 IN.PACT Admiral Demonstrates Consistent and Durable Outcomes in New Two-Year Japan Data and IN.PACT Global Critical Limb Ischemia Cohort Analysis
Jan 26, 2018 Medtronic Launches IDE Study to Evaluate the Abre™ Venous Self-Expanding Stent System in Patients with Deep Venous Disease
Jan 24, 2018 Medtronic Launches ENCHANT Study to Evaluate ChEVAR Parallel Graft Technique with the Endurant™ II/IIs Stent Graft System
Nov 2, 2017 Medtronic Evolut™ PRO TAVR System with Advanced Sealing Maintains Excellent Outcomes Over Time
Nov 1, 2017 Independent Study Shows New Data on Shortened DAPT in STEMI Patients with Medtronic Resolute Integrity Drug-Eluting Stent
Nov 1, 2017 Medtronic Unveils Strong Early Outcomes for the Intrepid™ Transcatheter Mitral Valve Replacement (TMVR) System
Jul 31, 2017 Medtronic Announces CE Mark and European Launch of CoreValve™ Evolut™ PRO Transcatheter Valve with Advanced Sealing
Jul 10, 2017 FDA Gives Approval to Medtronic's CoreValve for Use in Patients at Intermediate Risk for Surgical Valve Replacement
May 1, 2017 Medtronic Launches Resolute Onyx™ Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes
Mar 22, 2017 Medtronic Receives FDA Approval for CoreValve™ Evolut™ Pro Transcatheter Valve with Advanced Sealing
Mar 17, 2017 Landmark SURTAVI Clinical Trial Shows Transcatheter Aortic Valve Replacement (TAVR) with the Self-Expanding Platform Performs as Well as Surgery in Intermediate Risk Severe Aortic Stenosis Patients
Mar 10, 2017 Medtronic Announces Medicare Reimbursement for the First and Only Leadless Pacemaker Available for Use in the U.S.
Mar 9, 2017 Medtronic Launches Below-The-Knee Clinical Study in Europe for Treatment of PAD Using New Drug-Coated Balloon Technology
Feb 27, 2017 New Analysis of Reverse Trial Shows Medtronic CRT Devices Cost-Effective, While Helping Patients with Mild Heart Failure Live Longer
Feb 13, 2017 Medtronic Expands Coronary Portfolio to Include New DxTerity™ Diagnostic Catheters and Suite of Tools for the Transradial Approach
Feb 9, 2017 First Drug-Coated Balloon (DCB) Study Results in Japan Demonstrate Consistent Clinical Outcomes with Other Medtronic DCB Studies
Feb 1, 2017 Medtronic CardioInsight Mapping Solution Cleared by FDA
Jan 24, 2017 Medtronic Announces CE Mark for New Lower Profile HawkOne 6F Directional Atherectomy System
Jan 17, 2017 Medtronic Announces CE Mark and European Launch of Recaptureable TAVI System Now Available for Severe Aortic Stenosis Patients with Large Anatomies
Dec 6, 2016 Medtronic's Endurant™ II/IIs Stent Graft System Receives CE Mark for Use with ChEVAR Parallel Graft Technique
Dec 1, 2016 Medtronic Announces Reimbursement Approval and Launch of CoreValve™ Evolut™ R System in Japan
Nov 15, 2016 Medtronic's Endurant™ II/IIs Stent Graft System Delivers Positive Outcomes in Patients with Challenging Aortic Aneurysms
Nov 1, 2016

Medtronic Harmony™ Transcatheter Pulmonary Valve Demonstrates Positive Early Clinical Outcomes at One Year

Nov 1, 2016 Medtronic CoreValve™ Evolut R™ System Shows Exceptional Clinical Outcomes at One Year
Oct 31, 2016 First Clinical Data of Medtronic Drug-Filled Stent Show Positive Outcomes
Oct 31, 2016 New Data on Medtronic Evolut™ R TAVR System Show Excellent 'Real-World' Outcomes in Global Patient Population
Oct 30, 2016 Independent Study Finds Biodegradable Polymer Stents Provide No Clinical Benefit Over Resolute Integrity™ DES
Oct 26, 2016 Medtronic Announces FDA Approval of New Recaptureable TAVR System Available for Severe Aortic Stenosis Patients with Large Anatomies
Oct 24, 2016 Medtronic Receives FDA Clearance of New Lower Profile HawkOne 6F Directional Atherectomy System
Oct 13, 2016 Medtronic Cardiac Devices Gain FDA Approval to Enable Patient Access to the Most Advanced Diagnostic Imaging
Sep 20, 2016 Medtronic Valiant Captivia Demonstrates Safety and Efficacy at Three Years
Sep 19, 2016 New Data Presented in VIVA Late Breaking Clinical Trials Demonstrate Durability, Safety and Efficacy for the Medtronic In.Pact Admiral DCB
Sep 13, 2016 Medtronic Receives FDA Approval of First Drug-Coated Balloon for Treatment of In-Stent Restenosis (ISR)
Aug 29, 2016 Medtronic Technologies Improve Delivery of Cardiac Resynchronization Therapy
Aug 28, 2016 New Long-Term Data Reinforce Safety Benefits of the World's Smallest Pacemaker
Aug 1, 2016 Medtronic CoreValve™ Evolut™ R System First TAVI to Receive CE Mark for Intermediate Risk Aortic Stenosis Patients
Apr 6, 2016 FDA Approves World's Smallest Pacemaker for U.S. Patients
Apr 3, 2016 Medtronic CoreValve® System Maintains Survival Advantages Over Surgery in High Risk Aortic Stenosis Patients at Three Years
Apr 3, 2016 Medtronic Announces Early Data and Completes Enrollment in CE Mark Cohort in Drug-Filled Stent Trial
Apr 2, 2016 Medtronic CoreValve® System Demonstrates Superior Survival to Surgery in Aortic Stenosis Patients with Lower STS Scores
Mar 7, 2016 Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve™ Evolut™ R System in 'Real-World' Setting
Feb 22, 2016

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

Feb 22, 2016 Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans
Feb 18, 2016 Meta-Analysis Shows Medtronic's Solitaire™ Stent Retriever Device Improves Functional Outcomes for Acute Ischemic Stroke Patients; Reduced Mortality in Patients 80+
Feb 9, 2016 First Patient Treated with Medtronic Valiant TAAA Stent Graft System in Thoracoabdominal Aortic Aneurysm Study
Feb 5, 2016 Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators
Feb 1, 2016 Medtronic Adds New Resolute Onyx™ Drug-Eluting Stent Sizes and Expands Indications
Jan 29, 2016 Medtronic to Present Data on Micra® Transcatheter Pacing System at Upcoming FDA Advisory Committee Meeting
Jan 11, 2016 Medtronic IN.PACT Admiral DEB Receives CE Mark for Treatment of AV Access In Patients with End-Stage Renal Disease
Dec 14, 2015 Medtronic Announces New High-Tech Facility in Galway; Building on Global Synergies
Nov 17, 2015 Medtronic's Endurant AAA Stent Graft Delivers Durable, Consistent and Proven Outcomes at Four Years in Real-World Setting
Nov 16, 2015 Medtronic Showcases Aortic Leadership in Innovation with Clinical Release and Pipeline at VEITH 2015
Nov 9, 2015 World's Smallest Pacemaker, Medtronic Micra® TPS, Meets Global Clinical Trial's Safety and Effectiveness Endpoints
Nov 2, 2015 REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease
Nov 2, 2015 IN.PACT Admiral Drug-Coated Balloon Cost-Effectiveness Study and Global Study Results of In-Stent Restenosis Population Highlighted in Late Breaking Clinical Trials at VIVA 2015
Nov 2, 2015 Medtronic Unveils New Aortic and Peripheral Data from Two Late-Breaking Clinical Trials at VIVA 2015
Oct 14, 2015 Medtronic CoreValve® Evolut® R System Demonstrates Exceptional Results at One Year
Oct 14, 2015 Medtronic Drug-Coated Balloon Sustains Superiority Over Balloon Angioplasty at Two Years in Patients with Peripheral Arterial Disease
Oct 13, 2015 Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations
Oct 12, 2015 Medtronic CoreValve® System Demonstrates Excellent Clinical Outcomes in First Report of 'Real-World' U.S. Experience
Oct 12, 2015 Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants
Oct 6, 2015 Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015
Oct 5, 2015 Medtronic's Valiant® Thoracic Stent Graft System Demonstrates Durability After Five Years
Oct 2, 2015 Medtronic Completes Acquisition of Twelve, Inc.
Aug 31, 2015 Medtronic Acquires Medina Medical
Aug 31, 2015 Medtronic Study Detects Gene Associated with Sudden Cardiac Death
Aug 25, 2015 Medtronic to Acquire Twelve, Inc., Developer of Transcatheter Mitral Valve Replacement Device
Aug 3, 2015 CMS Grants New Technology Add-On Payment for Inpatient Use of Medtronic's Drug-Coated Balloon
Jun 23, 2015 Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.
Jun 20, 2015 Endurant AAA Stent Graft Maintains Durable, Consistent and Proven Outcomes for Abdominal Aortic Aneurysm Repair in Long-Term Follow-Up
Jun 10, 2015 Medtronic Initiates U.S. Launch of Fortrex™ PTA Balloon
May 20, 2015 Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions
May 15, 2015 Global Clinical Trial Finds Medtronic Micra® Transcatheter Pacemaker Meets Initial Safety and Performance Measures
May 14, 2015 Global Trial Finds Medtronic Micra® Transcatheter Pacemaker Meets Initial Safety Measures in Wide Range of Patients
Apr 29, 2015 Endurant AAA Stent Graft System from Medtronic Delivers Consistently Strong Results in Abdominal Aortic Aneurysms with Short and Standard 'Neck' Lengths
Apr 21, 2015 Medtronic Begins Enrollment in Feasibility Study of Valiant 'Mona LSA' Branch Thoracic Stent Graft System
Apr 14, 2015 Medtronic Announces CE Mark of World's Smallest Pacemaker, Micra Transcatheter Pacing System
Apr 14, 2015 Medtronic to Develop Stent Graft System for Endovascular Repair of Thoracoabdominal Aortic Aneurysms Under Exclusive Patent License Agreement with Sanford Health
Apr 9, 2015 Medtronic Initiates U.S. Launch of HawkOne™ Directional Atherectomy System for Treatment of Peripheral Arterial Disease
Apr 1, 2015 EverFlex™ Peripheral Stent from Medtronic Delivers Sustained Patency in Long, Complex Lesions
Apr 1, 2015 Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation
Mar 31, 2015 Medtronic CoreValve® System Receives FDA Approval for Transcatheter Valve-In-Valve Procedures
Mar 30, 2015 Medtronic Announces Japanese Regulatory Approval of CoreValve® System
Mar 15, 2015 Medtronic CoreValve® System Sustains Superior Survival Benefit Over Open Heart Surgery at Two Years
Mar 14, 2015 Medtronic to Initiate Clinical Study of Drug-Filled Stent Following Successful Preclinical Results
Mar 14, 2015 Medtronic CoreValve® Evolut™ R System Yields Exceptional Outcomes in First Clinical Study
Mar 12, 2015 Medtronic Initiates Pivotal Studies of Resolute Onyx™ Drug-Eluting Stent in United States
Feb 19, 2015 Medicare Approves Transitional Pass-Through Payment for Outpatient Use of Medtronic Drug-Coated Balloon
Feb 16, 2015 Medtronic Announces CE Mark and European Launch of the Euphora™ Semicompliant Coronary Balloon Catheter
Feb 13, 2015 The American Heart Association - American Stroke Association and Medtronic Collaborate to Reduce Recurrent Strokes
Feb 11, 2015 Medtronic Insertable Cardiac Monitors Detect Atrial Fibrillation in Stroke Patients in 'Real-World' Study
Feb 4, 2015 Medtronic Starts U.S. Launch of IN.PACT Admiral Drug-Coated Balloon for Treatment of Peripheral Arterial Disease in Upper Leg
Feb 2, 2015 Medtronic Expands Access to the Next Generation CoreValve Evolut R System with New Valve Sizes
Jan 26, 2015 Medtronic Completes Acquisition of Covidien
Jan 26, 2015 Medtronic's Acquisition of Covidien Approved by Irish High Court; Anticipated to Close on January 26, 2015
Jan 5, 2015 Medtronic Drug-Coated Balloon Receives FDA Approval for Treating Peripheral Artery Disease in Upper Leg
Dec 22, 2014 Medtronic Drug-Coated Balloon for Peripheral Artery Disease Tops Standard Balloon Angioplasty in Landmark Study
Dec 9, 2014 Endurant 'AAA' Stent Graft from Medtronic Continues to Deliver Durable, Consistent and Proven Outcomes
Nov 26, 2014 Medtronic Acquisition of Covidien Receives U.S. FTC Clearance
Nov 12, 2014 Medtronic Adds to Endurant 'AAA' Stent Graft System
Nov 4, 2014 Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study
Nov 3, 2014 Medtronic Launches Resolute Onyx™ Drug-Eluting Stent Following CE Mark
Oct 14, 2014 Medtronic Announces FDA Approval of Pacing Lead for Full-Body MRI Scans
Oct 13, 2014 Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access
Sep 17, 2014 Medtronic Elects Elizabeth Nabel to the Board of Directors
Sep 16, 2014 Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease
Sep 15, 2014 Medtronic Launches SEEQ™ Wearable Cardiac Monitoring System in United States
Sep 13, 2014 Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients
Sept 13, 2014 Medtronic CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients
Sep 11, 2014 Medtronic NC Euphora™ Coronary Balloon Receives FDA Clearance
Sep 10, 2014 Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R
Sep 3, 2014 Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System
Sep 2, 2014 Medtronic CFO Gary Ellis to Speak at Morgan Stanley Healthcare Conference
Jun 25, 2014 Study Published in The New England Journal of Medicine Finds Medtronic Insertable Cardiac Monitors Detect Atrial Fibrillation in Stroke Patients Better Than Standard Care
Jun 19, 2014 Medtronic Announces Preliminary Outcomes for World's Smallest Cardiac Pacemaker
Jun 12, 2014 Medtronic CoreValve® System Receives FDA Approval for Patients at High Risk for Surgery
Jun 11, 2014 Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease
Jun 4, 2014 Medtronic Expands Availability of Market-Leading Aortic & Peripheral Solutions to U.S. Market
May 21, 2014 Medtronic CoreValve® System Demonstrates Positive Clinical Performance at Two Years in 'Real World' ADVANCE Study
May 20, 2014 Medtronic Announces CE Mark and Launch of NC Euphora™ Coronary Balloon
May 20, 2014 Medtronic Settles Global Patent Litigation with Edwards Lifesciences
May 20, 2014 Medtronic Reports Fourth Quarter and Fiscal Year 2014 Earnings
Apr 29, 2014 Medtronic Reveals Positive Outcomes for CoreValve® Patients Treated via Alternative Access Routes
Apr 21, 2014 Federal Appeals Court Agrees to Medtronic Request to Postpone Injunction
Apr 19, 2014 Update on CoreValve Federal District Court Ruling; Court Agrees to Expedited Appeal
Apr 18, 2014 Endurant AAA Stent Graft from Medtronic Continues Exceptional Long-Term Performance in Observational Studies
Apr 11, 2014 Medtronic to Appeal Federal District Court Ruling
Apr 5, 2014 'IN.PACT Admiral' Drug-Coated Balloon From Medtronic Outperforms Standard Angioplasty In Landmark Study
Mar 31, 2014 Medtronic CoreValve® System Demonstrates Long-Term Durability
Mar 30, 2014 World's First Transcatheter Valve, Medtronic Melody® Transcatheter Pulmonary Valve Shows Positive Clinical Outcomes in Real-World Study
Mar 30, 2014 Medtronic Global SYMPLICITY Registry Shows Strong Safety Profile of the Symplicity™ Renal Denervation System
Mar 29, 2014 Medtronic CoreValve® System Results Superior to Open-Heart Surgery at One Year in U.S. Pivotal Trial
Mar 29, 2014 Medtronic Releases Results of SYMPLICITY HTN-3
Mar 10, 2014 Medtronic Seeking Long-Distance Runners Who Benefit From Medical Technology
Mar 6, 2014 Medtronic Wins European Patent Office Ruling
Feb 19, 2014 Medtronic Announces Global Launch of Miniature Cardiac Monitor, Reveal LINQ™ ICM
Feb 18, 2014 Medtronic Reports Third Quarter Earnings
Feb 13, 2014 Medtronic Launches "TOTAL Across" Crossing Catheter in Europe
Feb 11, 2014 Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2014
Jan 28, 2014 Medtronic Relocates Its Regional Headquarters to Dubai
Jan 28, 2014 Valiant Captivia Thoracic Stent Graft System From Medtronic Receives FDA Approval for Treating Aortic Dissections
Jan 17, 2014 Medtronic CoreValve® System Obtains Early FDA Approval on Exceptional Clinical Performance
Jan 15, 2014 Medtronic to Appeal Federal District Court Verdict
Jan 9, 2014 Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint
Dec 17, 2013 Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension
Dec 9, 2013 Medtronic Announces First Human Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker
Dec 5, 2013 Medtronic Announces CE Mark and TGA Listing for the Symplicity Spyral™ Multi-Electrode Catheter and Symplicity G3™ Generator
Nov 25, 2013 Endurant II AAA Stent Graft from Medtronic Delivers Durable, Consistent and Proven Outcomes in Real-World Setting
Nov 20, 2013 Valiant 'Mona LSA' Stent Graft System from Medtronic Demonstrates Proof of Concept in Early Feasibility Study
Nov 14, 2013 Medtronic to Resume Sales of CoreValve System in Germany
Nov 5, 2013 Medtronic Announces FDA Approval to Enroll First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension
Oct 31, 2013 In Trial of Rivals, Medtronic's Resolute Integrity Stent Outperforms Promus Element Stent on Longitudinal Strength
Oct 31, 2013 In Studies of Medtronic Stents, Patients Who Interrupted Dual Antiplatelet Therapy Early Saw No Increased Thrombosis Risk
Oct 30, 2013 Medtronic CoreValve U.S. Pivotal Trial Affirms Benefits of Self-Expanding Transcatheter Aortic Valve Replacement in Patients Treated Via Alternative Access Routes
Oct 30, 2013 Medtronic Presents Three-Year Results From SYMPLICITY HTN-2 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity™ Renal Denervation System
Oct 29, 2013 Medtronic CoreValve U.S. Pivotal Trial Results Reveal Positive Outcomes for Patients
Oct 22, 2013 Medtronic Initiates Clinical Study of Recapturable CoreValve Evolut R
Oct 21, 2013 Medtronic Launches New Device To Remove Coronary Thrombus
Oct 17, 2013 Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013
Sep 24, 2013 FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries
Sep 15, 2013 Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant And Sustained Drops In Blood Pressure After Treatment With The Symplicity™ Renal Denervation System
Sep 2, 2013 Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity™ Renal Denervation System from the Global SYMPLICITY Registry
Aug 15, 2013 Medtronic Submits First 'PMA' Module for IN.PACT Admiral Drug-Eluting Balloon
Jul 12, 2013 Medtronic Issues Statement on Ruling in Germany
Jun 3, 2013 Medtronic Reaches Major Milestone in Clinical Program for 'IN.PACT Admiral' Drug-Eluting Balloon
May 31, 2013 Endurant AAA Stent Graft Delivers Durable Outcomes for Abdominal Aortic Aneurysm Repair
May 30, 2013 Medtronic Garners First-Of-Its-Kind FDA Approval for 'AUI' Device with Endurant II AAA Stent Graft System
May 23, 2013 Medtronic CoreValve® System Gains First Approval for Transcatheter Valve-In-Valve Procedures
May 23, 2013 Medtronic's In.Pact Falcon Drug-Eluting Balloon Yields Positive Outcomes in Small Coronary Arteries
May 22, 2013 For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results
May 20, 2013 Medtronic Receives 'CE' Mark for 'Export Advance' Aspiration Catheter
Mar 14, 2013 With Medtronic Resolute Stent, Interrupting Dual Antiplatelet Therapy After One Month Showed No Increased Safety Risk in Robust Analysis
Mar 7, 2013 Medtronic Submits IDE to FDA for U.S. Randomized Clinical Trial for Uncontrolled Hypertension Patients with Systolic Blood Pressure Between 140-160 mm Hg
Mar 6, 2013 Symplicity™ Renal Denervation System One of First Devices Accepted to Participate in Concurrent Review for Joint FDA Premarket Approval and Medicare National Coverage Determination
Mar 4, 2013 Medtronic Approved to Update Resolute Integrity Stent's 'CE' Mark Labeling on Dual Antiplatelet Therapy
Feb 28, 2013 Medtronic's Engager™ Transcatheter Aortic Valve Gets European Approval
Feb 25, 2013 FDA Approves Longer Lengths of Medtronic's Resolute Integrity Stent
Feb 19, 2013 Medtronic Reports Third Quarter Earnings; Drug-Eluting Stent Revenue Up 42%
Feb 13, 2013 Medtronic Announces FDA Approval and Launch of Its Advisa MRI Pacemaker System
Feb 11, 2013 Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2013
Jan 24, 2013 Medtronic Launches Lower-Extremity Indication for Complete 'SE' Vascular Stent Internationally
Jan 23, 2013 Medtronic Drug-Eluting Balloon Study Completes Enrollment
Dec 17, 2012 One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Published in Circulation
Nov 19, 2012 Medtronic's Endurant AAA Stent Graft Delivers Durable Outcomes for Abdominal Aortic Aneursym Repair
Nov 13, 2012 FDA Approves Medtronic Stent Graft For Aortic Transection Repair
Oct 24, 2012 Medtronic Engages Cardiologists In 'World Diabetes Day'
Oct 23, 2012 Medtronic Stent Successfully Treats Long Lesions And Small Vessels, Two Characteristics Typical Of Patients With Diabetes, In Multiple Studies
Oct 22, 2012 Analysis Of Medtronic Stent Finds Early Cessation Of Dual Antiplatelet Therapy Caused No Increased Risk Of Blood Clots To One Year
Oct 22, 2012 Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients
Oct 22, 2012 New Study Results Show High Survival Rates And Improved Quality Of Life For Patients With Medtronic Corevalve® System
Oct 5, 2012 Medtronic Launches New Angioplasty Catheter for Below-the-Knee Arteries
Oct 5, 2012 Medtronic Completes Enrollment in Landmark Study of IN.PACT Drug-Eluting Balloon in Peripheral Artery Disease
Oct 3, 2012 Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension
Oct 2, 2012 New Data Reinforce Positive Clinical Outcomes for Direct Aortic Implants Using the Medtronic CoreValve® System
Oct 1, 2012 Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan
Sep 26, 2012 Medtronic Gains CE Mark for CoreValve® Evolut™ 23mm Transcatheter Aortic Valve
Sep 21, 2012 Medtronic Commits $6 Million to Address Cardiovascular Disease, Diabetes Care for Underserved in India
Sep 12, 2012 Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension
Aug 29, 2012 Medtronic Completes High Risk Patient Enrollment in CoreValve® U.S. Pivotal Trial and Gains FDA Approval to Study Intermediate Risk Patients in Global SURTAVI Trial
Aug 28, 2012 Medtronic Launches Resolute Integrity Coronary Stent System in Japan
Aug 27, 2012 Medtronic Study Confirms Long-Term Safety of Drug-Eluting Coronary Stents
Jul 18, 2012 Medtronic Begins Global Clinical Trial Evaluating CoreValve® System Implantation in Intermediate-Risk Patients
Jun 21, 2012 Medtronic Stent Graft Chosen by U.S. FDA for Innovative Program
May 16, 2012 Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries
May 15, 2012 Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
Apr 27, 2012 Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment
Apr 17, 2012 Medtronic Announces Global Drug-Eluting Balloon Study
Apr 13, 2012 Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study
Mar 25, 2012 Medtronic Symplicity™ Renal Denervation System Demonstrates Significant and Sustained Blood Pressure Reduction Out to Three Years
Mar 24, 2012 Data Presented at ACC Reinforce Positive Clinical Outcomes for Patients Receiving Medtronic's CoreValve® System
Mar 24, 2012 Medtronic Resolute® Drug-Eluting Stent Delivers Durable Clinical Outcomes Through Two Years in Major Studies
Feb 17, 2012 Medtronic Resolute Integrity™ Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease
Feb 13, 2012 Medtronic Launches Two New Clinical Programs to Evaluate the Use of Symplicity™ Renal Denervation System Across Multiple Conditions
Feb 8, 2012 Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
Jan 24, 2012 Medtronic Completes Enrollment of Extreme Risk Patient Group in CoreValve® U.S. Pivotal Trial
Jan 17, 2012 Medtronic Endurant® II AAA Stent Graft System Launches Internationally With CE Mark
Nov 8, 2011 Medtronic Resolute® Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease
Nov 8, 2011 Study of Medtronic Endeavor® Drug-Eluting Stent Demonstrates Long-Term Advantages Over Taxus® DES
Nov 7, 2011 Medtronic CoreValve® System Gains CE Mark for New Direct Aortic Approach to Transcatheter Aortic Valve Implantation
Nov 4, 2011 Medtronic's Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
Aug 23, 2011 Medtronic Reports First Quarter Earnings
Jul 25, 2011 Medtronic Resolute® Drug-Eluting Stent Shows Superiority to Taxus ® DES in Study of Patients with Coronary Artery Disease
Jun 18, 2011 VALOR II Study Highlights Strengths of Valiant® Thoracic Stent Graft from Medtronic
May 18, 2011 Medtronic Resolute® Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease
May 17, 2011 Medtronic CoreValve® Multi-Center Study Shows Rapid and Sustained Health-Related Quality-Of-Life Improvements
May 16, 2011 Medtronic Advances Research on Peripheral Devices, Highlights Upcoming Presentations
Apr 4, 2011 Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes In Major Studies
Mar 28, 2011 Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11
Mar 14, 2011 Medtronic Pledges $1 Million to Relief Efforts in Japan
Mar 3, 2011 Medtronic Seeking Long-Distance Runners Who Benefit From Medical Technology
Feb 18, 2011 Largest Study of Medtronic CoreValve® System Confirms Positive Clinical Outcomes
Jan 18, 2011 Medtronic Revises Design of CoreValve® U.S. Pivotal Trial
Jan 13, 2011 Medtronic Completes Acquisition of Ardian
Dec 21, 2010 Landmark Medtronic CoreValve® U.S. Clinical Trial Begins
Dec 21, 2010 Med-Tech Advance for 'Silent Killer': FDA Approves Medtronic Device to Fix Abdominal Aortic Aneurysms
Dec 9, 2010 Medtronic CoreValve® System Gains CE Mark for New Subclavian Approach to Transcatheter Aortic Valve Implantation
Nov 22, 2010 Medtronic Signs Agreement to Acquire Ardian
Nov 19, 2010 Medtronic Presents 30-Day Data On Valiant® Thoracic Stent Graft
Nov 19, 2010 Medtronic Presents One-Year Data On Endurant® Stent Graft
Nov 17, 2010 Medtronic Unveils EVARpro® Suite Of Services To Streamline Clinical Use Of Aortic Stent Grafts
Nov 1, 2010 Medtronic Receives FDA Approval of Talent Captivia® System for Endovascular Treatment of Thoracic Aortic Aneurysms
Oct 15, 2010 Medtronic Clinical Trial Receives FDA Approval to Evaluate New CoreValve® System for Aortic Valve Implantation
Sep 28, 2010 Medtronic Advances Research on Drug-Eluting Balloons for Coronary and Peripheral Artery Disease
Sep 22, 2010 Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance In Second 'All Comers' Study
Sep 20, 2010 Medtronic Receives FDA Approval of Integrity® Coronary Stent
Sep 17, 2010 Medtronic Showcases Cardiovascular Devices at TCT 2010
Sep 10, 2010 Medtronic Releases 2010 Corporate Citizenship Report
Sep 7, 2010 Medtronic Gains CE Mark for Enhanced CoreValve® Delivery Catheter System with AccuTrak Stability Layer
Aug 30, 2010 Medtronic Launches Resolute Integrity Drug-Eluting Stent In Europe
Aug 8, 2010 Medtronic Opens Patient Care Centre in Beijing, China
Aug 6, 2010 Medtronic Completes Enrollment in Clinical Study of Complete SE® (Self-Expanding) Vascular Stent
Aug 5, 2010 First Patient Treated with Medtronic’s Valiant® Thoracic Stent Graft in Aortic Dissection Trial
May 26, 2010 Medtronic CoreValve® System Shows Long-Term Efficacy and Durability in Pivotal Trial
May 25, 2010 Multiple European Clinical Registries Show Important Benefits of Medtronic CoreValve® Transcatheter Aortic Valve System
May 25, 2010 Medtronic's Resolute® Drug-Eluting Stent Matches Market-Leading Rival in Large Head-To-Head Study
May 20, 2010 Cardiovascular Devices from Medtronic Featured Prominently at EuroPCR
May 19, 2010 First Patient Treated with Valiant® Thoracic Stent Graft in Medtronic ’s “RESCUE” Clinical Study
Apr 21, 2010 Medtronic Receives FDA Approval for New Indication for Complete® SE Vascular Stent
Mar 14, 2010 Medtronic's Endeavor Stent Continues to Demonstrate Compelling and Consistent Long-Term Clinical Results
Mar 12, 2010 Medtronic Starts International Study of CoreValve® Transcatheter Aortic Valve System
Jan 25, 2010 Medtronic to Acquire Invatec and Affiliated Companies
Jan 25, 2010 Medtronic Receives FDA Approval for First Replacement Heart Valve Implanted Without Surgery
Jan 21, 2010 Medtronic Pledges $1 Million to Haiti Earthquake Relief
Jan 15, 2010 Medtronic Pledges Over $250,000 to Haiti Earthquake Relief
Dec 8, 2009 Medtronic Hires Renowned Cardiologist as Vice President of Medical Affairs for Coronary and Peripheral Business
Dec 2, 2009 Medtronic Names Michael J. Coyle as Executive Vice President and Group President of Cardiology Businesses
Nov 25, 2009 Medtronic CEO William Hawkins to Speak at 21st Annual Piper Jaffray Healthcare Conference
Nov 24, 2009 Medtronic Second Quarter Revenue Increases 8% to $3.838 Billion; Raises EPS Guidance for Current Fiscal Year
Nov 19, 2009 Medtronic Chairman and CEO Bill Hawkins Comments on U.S. Senate's Revised Medical Device Industry Fee Proposal
Oct 13, 2009 Medtronic Starts Study of Interventional Erectile Dysfunction Therapy
Oct 5, 2009 2009 Medtronic Twin Cities Marathon “Global Heroes” Celebrate Accomplishment
Sep 21, 2009 Medtronic’s Resolute® Drug-Eluting Stent Maintains Strong, Sustained Efficacy and Safety in Long-Term Follow-Up
Sep 21, 2009 Endeavor® Stent Reduced Risk of Heart Attack/Cardiac Death by 48% at Three Years Compared to Taxus ® Stent in Large Study
Sep 18, 2009 Medtronic Expects New Data on Drug-Eluting Stents and Transcatheter Heart Valves to Feature at TCT 2009
Aug 25, 2009 Medtronic Reports First Quarter Revenue of $3.9 Billion
Aug 14, 2009 Medtronic to Announce Financial Results for Its First Fiscal Quarter
Aug 6, 2009 Medtronic Awarded $57 Million in Patent Dispute with AGA Medical Corporation
Jul 27, 2009 Medtronic and Abbott Laboratories Resolve Global Vascular Patent Disputes
Jun 15, 2009 Talent Stent Graft Shows Durable Performance in Patients with Abdominal Aortic Aneurysms
May 20, 2009 Medtronic’s CoreValve Shows Subclavian Access Success in Patients Contraindicated for Femoral Approach
May 19, 2009 Endeavor Drug-Eluting Stent Is First to Receive CE Mark for Treating Acute Coronary Syndrome
May 19, 2009 New Data From ENDEAVOR-II Challenges Conventional Wisdom on Drug-Eluting Stents
May 18, 2009 Medtronic to Participate in the Piper Jaffray Post-EuroPCR Summit
May 15, 2009 New Data on Endeavor Stent's Long-Term Safety and Efficacy to Be Featured at Interventional Cardiology Congress
May 14, 2009 Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
Apr 27, 2009 Medtronic Starts Enrollment in THRIVE, U.S. Post-Market Study of the Talent ™ Thoracic Stent Graft
Apr 3, 2009 Medtronic Launches Driver Sprint RX Coronary Stent System Worldwide

Source: Medtronic plc

Angioplasty.Org Home •  PatientCenter

this press release is posted as a reader service by Angioplasty.org,
an editorially independent informational health site
which has received unrestricted educational grants from
Medtronic plc, TCROSS NEWS, Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
All content, including text, photos and video
©Copyright Venture Digital LLC 1996-2021